Philips and TriHealth Announce Multi-year Partnership at zheart of New TriHealth Heart & Vascular Institute On the Campus of Bethesda North Hospital

With access to innovative healthcare technologies, clinicians can continue to provide exceptional care to local and surrounding communities and deliver on Quadruple Aim

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a long-term strategic partnership with TriHealth, a leading Cincinnati-based integrated healthcare delivery system, to adopt Philips’ integrated portfolio of cardiology solutions for its new TriHealth Heart & Vascular Institute on the campus of Bethesda North Hospital and the Harold and Eugenia Thomas Comprehensive Care Center. The agreement allows TriHealth to expand cardiac care and deliver on its promise to the community: provide high quality care, act for the benefit of the community, cooperate with the physicians and other providers to coordinate health services, and to educate the next generation of healthcare providers.

TriHealth is a full-service, not-for-profit health system that services three Ohio counties as well as Kentucky residents living close to the state border, with a wide range of clinical, educational, preventive and social programs. As one of the top integrated health systems in greater Cincinnati, TriHealth is committed to providing access to the highest quality medical services for the communities it serves. Over the last few years, TriHealth has made significant investments, including its recent affiliation with the Cleveland Clinic Heart, Vascular & Thoracic Institute, to establish itself as the region’s destination heart and vascular program. Partnering with Philips is the latest in TriHealth enterprise collaborations focused on sharing best practices and developing new treatments and therapies to achieve the best possible outcomes for heart patients across the region.

“Our mission at TriHealth is to improve the health status of the people we serve. The reimagined spaces and workflow in the new Heart & Vascular Institute will enable us to meet our clinical and operational goals, while the new business model will allow us to adopt the technologies that we need, when we need them,” said Jamie Easterling, president and COO of Bethesda North Hospital. “We see tremendous value in our partnership with Philips. Its industry-leading technology, design services, training, ongoing education and support provide all the tools for us to deliver unmatched patient care.”

The TriHealth Heart & Vascular Institute is comprised of nine interventional suites where patients can be diagnosed and treated with a range of minimally-invasive cardiovascular procedures. The rooms are equipped with Philips image-guided therapy solutions, including Azurion, and Philips cardiovascular ultrasound systems Affiniti and EPIQ, for improved imaging, simplified navigation, more efficient AI-enhanced workflows and shorter procedure times. The co-location of the labs allows for easy collaboration with specialists, who are only steps away, for consultation during procedures and interventions. For example, an electrophysiologist can easily be pulled into a procedure for a pacemaker implant. In situations like this, standardizing on Philips technology provides consistency across the labs and ensures physicians have familiarity with the system regardless of the lab in which they are working.

“TriHealth understands that it takes both technology and true partnership to deliver the innovation needed to address today’s healthcare challenges,” said Jeff DiLullo, chief market leader, Philips North America. “Through this collaboration, Bethesda North is becoming the region’s premier destination for heart and vascular care, giving clinicians access to the best technology available so they can provide their patients the quality care they need, and do so closer to home.”

Later this year, TriHealth will open a new reception/waiting area, nursing stations and pre/post operative bays. Patients and staff can expect additional technologies such as patient monitoring, including advanced clinical decision support tools and smart alarms, which can help clinicians intervene before patients have an adverse event, and Philips ultra-mobile Lumify handheld ultrasound, the company’s tablet-based ultrasound that provides telehealth capabilities. The partnership also consists of technology management plans, helping to ensure the health system can benefit from the latest technology innovations which will help them drive their strategy and deliver on their mission.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy